Pathstone Holdings
SOPH icon

Pathstone Holdings’s SOPHiA GENETICS SOPH Stock Holding History

Pathstone Holdings’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Buy
32,203
+738
+2% +$3.75K ﹤0.01% 2249
2026
Q1 		$156K Sell
31,465
-738
-2% -$3.59K ﹤0.01% 2137
2025
Q4 		$150K Buy
32,203
+88
+0.3% +$399 ﹤0.01% 2141
2025
Q3 		$153K Sell
32,115
-3,871
-11% -$13.3K ﹤0.01% 2235
2025
Q2 		$112K Sell
35,986
-4,036
-10% -$12K ﹤0.01% 2107
2025
Q1 		$133K Hold
40,022
– – ﹤0.01% 2129
2024
Q4 		$125K Buy
40,022
+26,000
+185% +$88.5K ﹤0.01% 2219
2024
Q3 		$51K Buy
+14,022
New +$57K ﹤0.01% 2291

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Pathstone Holdings's SOPH Position: Q2 2026 in Review

Pathstone Holdings increased its SOPHiA GENETICS (SOPH) stake by 2.3% in Q2 2026, buying an estimated $3.75K and bringing the position to 32,203 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Pathstone Holdings first reported a position in SOPH in Q3 2024 and has held it in 8 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Pathstone Holdings held 32,203 shares of SOPHiA GENETICS worth $185K as of Q2 2026.
  • Pathstone Holdings bought 738 SOPHiA GENETICS shares in Q2 2026, an estimated $3.75K.
  • SOPHiA GENETICS made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2249 holding.
  • Pathstone Holdings first reported a position in SOPHiA GENETICS in Q3 2024 and has held it in 8 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.